Incyte Corp (INCY)
67.49
+0.45
(+0.67%)
USD |
NASDAQ |
Oct 04, 16:00
67.52
+0.02
(+0.04%)
After-Hours: 20:00
Incyte Shareholders Equity (Annual): 5.190B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 5.190B |
December 31, 2022 | 4.370B |
December 31, 2021 | 3.770B |
December 31, 2020 | 2.611B |
December 31, 2019 | 2.598B |
December 31, 2018 | 1.926B |
December 31, 2017 | 1.631B |
December 31, 2016 | 419.47M |
December 31, 2015 | 171.16M |
December 31, 2014 | -81.63M |
December 31, 2013 | -193.11M |
December 31, 2012 | -174.96M |
December 31, 2011 | -227.08M |
December 31, 2010 | -88.64M |
December 31, 2009 | -102.38M |
December 31, 2008 | -220.75M |
Date | Value |
---|---|
December 31, 2007 | -159.52M |
December 31, 2006 | -84.91M |
December 31, 2005 | -19.40M |
December 31, 2004 | 78.52M |
December 31, 2003 | 154.33M |
December 31, 2002 | 302.41M |
December 31, 2001 | 440.20M |
December 31, 2000 | 622.69M |
December 31, 1999 | 170.30M |
December 31, 1998 | 179.60M |
December 31, 1997 | 145.70M |
December 31, 1996 | 45.20M |
December 31, 1995 | 46.80M |
December 31, 1994 | 24.00M |
December 31, 1993 | 16.10M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
2.598B
Minimum
2019
5.190B
Maximum
2023
3.708B
Average
3.770B
Median
2021
Shareholders Equity (Annual) Benchmarks
Syndax Pharmaceuticals Inc | 554.20M |
Eli Lilly and Co | 10.77B |
Merck & Co Inc | 37.58B |
Pfizer Inc | 89.01B |
Alnylam Pharmaceuticals Inc | -220.64M |